Age-associated risks of prophylactic anticoagulation in the setting of hip fracture
- 30 June 1994
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 96 (6) , 487-491
- https://doi.org/10.1016/0002-9343(94)90086-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Aging and the Anticoagulant Response to Warfarin TherapyAnnals of Internal Medicine, 1992
- The Association of Age with Dosage Requirement for WarfarinAge and Ageing, 1991
- Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapyThe American Journal of Medicine, 1989
- Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhageThe American Journal of Medicine, 1986
- WARFARIN SODIUM: STEADY-STATE PLASMA LEVELS AND PATIENT AGEClinical and Experimental Pharmacology and Physiology, 1978
- The influence of age on the response to anticoagulants.British Journal of Clinical Pharmacology, 1977
- Age as a determinant of sensitivity to warfarin.British Journal of Clinical Pharmacology, 1977
- Determinants of anticoagulant control in patients receiving warfarin.British Journal of Clinical Pharmacology, 1977
- WARFARIN SODIUM IN PREVENTION OF DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN PATIENTS WITH FRACTURED NECK OF FEMURThe Lancet, 1976
- Anticoagulation for Prevention of Thromboembolism Following Fractures of the HipNew England Journal of Medicine, 1966